Literature DB >> 25387851

High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer.

Satu Tiainen1, Ritva Tumelius, Kirsi Rilla, Kirsi Hämäläinen, Markku Tammi, Raija Tammi, Veli-Matti Kosma, Sanna Oikari, Päivi Auvinen.   

Abstract

AIMS: High amounts of tumour-associated macrophages (TAMs) and hyaluronan (HA) correlate with tumour aggressiveness in breast cancer, but the relationship between these parameters is unclear. The aim of this study was to assay the numbers of TAMs in 278 human breast cancer cases, and their correlations with HA-related factors, clinical variables, and outcome. METHODS AND
RESULTS: The immunoreactivities for CD163 and CD68 were considered as indicators for M2-like and all TAMs, respectively. The numbers of TAMs were counted in at least four hot spots, and averaged to represent the numbers of TAMs in each section. In the statistical analyses, the numbers were graded as either low or high according to the median. High numbers of TAMs correlated with a high tumour HA content, HA synthases, CD44 positivity, and poor outcome. The number of CD163-positive cells represented a strong independent prognostic factor. There was also a significant correlation between obesity and a high number of CD163-positive cells.
CONCLUSIONS: Concurrent increases in TAMs and HA in breast cancer indicate that the accumulation of HA facilitates macrophage infiltration and inflammatory responses during human breast cancer progression.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  CD163; CD68; Hyaluronan; breast cancer; hyaluronan synthase; obesity; tumour-associated macrophage

Mesh:

Substances:

Year:  2015        PMID: 25387851     DOI: 10.1111/his.12607

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  77 in total

1.  Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarization.

Authors:  Xixi Zhao; Jingkun Qu; Xu Liu; Jizhao Wang; Xingcong Ma; Xiaoyao Zhao; Qian Yang; Wanjun Yan; Zitong Zhao; Yuxin Hui; Haocheng Bai; Shuqun Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  A novel role of breast cancer-derived hyaluronan on inducement of M2-like tumor-associated macrophages formation.

Authors:  Guoliang Zhang; Lin Guo; Cuixia Yang; Yiwen Liu; Yiqing He; Yan Du; Wenjuan Wang; Feng Gao
Journal:  Oncoimmunology       Date:  2016-04-29       Impact factor: 8.110

Review 3.  Tumor microenvironment promotes breast cancer chemoresistance.

Authors:  Umar Mehraj; Abid Hamid Dar; Nissar A Wani; Manzoor A Mir
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-09       Impact factor: 3.333

4.  Prognostic Role of Immune Markers in Triple Negative Breast Carcinoma.

Authors:  Hulya Sahin Ozkan; Mustafa Umit Ugurlu; Perran Fulden Yumuk; Handan Kaya
Journal:  Pathol Oncol Res       Date:  2020-07-17       Impact factor: 3.201

5.  Blockade of p38 kinase impedes the mobilization of protumorigenic myeloid populations to impact breast cancer metastasis.

Authors:  Justin Zonneville; Sean Colligan; Sydney Grant; Alexandra Miller; Paul Wallace; Scott I Abrams; Andrei V Bakin
Journal:  Int J Cancer       Date:  2020-05-28       Impact factor: 7.396

6.  The interplay of growth differentiation factor 15 (GDF15) expression and M2 macrophages during prostate carcinogenesis.

Authors:  Sudha M Sadasivan; Yalei Chen; Nilesh S Gupta; Xiaoxia Han; Kevin R Bobbitt; Dhananjay A Chitale; Sean R Williamson; Andrew G Rundle; Deliang Tang; Benjamin A Rybicki
Journal:  Carcinogenesis       Date:  2020-08-12       Impact factor: 4.944

Review 7.  Cryoablation and Immunotherapy for Breast Cancer: Overview and Rationale for Combined Therapy.

Authors:  Helaina C Regen-Tuero; Robert C Ward; William M Sikov; Peter J Littrup
Journal:  Radiol Imaging Cancer       Date:  2021-02-26

Review 8.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.

Authors:  Irina Larionova; Gulnara Tuguzbaeva; Anastasia Ponomaryova; Marina Stakheyeva; Nadezhda Cherdyntseva; Valentin Pavlov; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

9.  KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.

Authors:  Yoshihisa Tokumaru; Masanori Oshi; Eriko Katsuta; Li Yan; Vikas Satyananda; Nobuhisa Matsuhashi; Manabu Futamura; Yukihiro Akao; Kazuhiro Yoshida; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

Review 10.  Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology.

Authors:  Xiaofei Yu; Chunqing Guo; Paul B Fisher; John R Subjeck; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2015-06-17       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.